期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性心肌梗死再灌注后心律失常的治疗与分析 被引量：4

在线阅读 下载PDF
导出
摘要 目的分析研究胺碘酮防止急性心肌梗死(AMI)再灌注恶性心律失常(RA)的作用。方法随机分成对照组和治疗组,每组各48例,对照组给予尿激酶常规溶栓治疗,治疗组溶栓前加用胺碘酮维持静脉滴注至少4h,监测RA的发生率。结果对照组RA、室颤及病死率分别为84.21%;18.42%,10.52%。而治疗组分别为48.64%、10.08%、2.7%。两组相比,差异有统计学意义("P<0.05")。结论胺碘酮能预防和减少AMI的RA、室颤发生率,提高室颤抢救成功率。
作者 董玉婉 万荫国
机构地区 河南省封丘县人民医院内科
出处 《当代医学》 2009年第24期64-64,共1页 Contemporary Medicine
关键词 胺碘酮 预防 再灌注性心律失常 急性心肌梗死 尿纤溶酶原激活物 溶栓
分类号 R542.22 [医药卫生—心血管疾病] R541.7 [医药卫生—心血管疾病]
  • 相关文献

参考文献4

二级参考文献27

  • 1Greene HL,Roden DM,Katz RJ,Woosley RL,Salerno DM,Henthorn RW.The Cardiac Arrhythmia Suppression Trial:first CAST then CAST II[J].J Am Coll Carciol,1992,19∶894-898.
  • 2Podrid PJ.Amiodarone:reevaluation of an old drug[J].Ann Intern Med,1995,122∶689-700.
  • 3Roden DM.Pharmacokinetics of amiodarone:implications for drug therapy[J].Am J Cardiol,1993,72∶45F-50F.
  • 4Singh BN,Venkatesh N,Nademanee K,et al.The historical development,cellular electrophysiology,and pharmacology of amiodarone[J].Prog Cardovasc D S,1989,31∶249-280.
  • 5Singh BN,Nademanee K.Amiodarone and thyroid function:clirical implications during antiarrhythmic therapy[J].Am Heart J,1983,106∶857-869.
  • 6Nattle S.Comparative mechanisms of action of antiarrhythmic drugs[J].Am J Cardiol,1993,72(16)∶13F-17F.
  • 7The CASCADE investigators:The Cascade study-randomized anti-arrhythmic drug therapy in survivors of cardiac arrest in Seattle[J].Am J Cardiol,1993,13∶442-449.
  • 8Levine JH,Massumi A,Scheinman MM,et al.Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias.The Intravenous Amiodarone Multicenter Trial Group[J].J Am Coll Cardiol,1996,27∶67-75.
  • 9Kowey PR,Levine JH,Herre JM,et al.Randomized,double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent,hemodynamically destabilizing ventricular tachycardia or fibrillation.The Intravenous Amiodarone Multicenter Investigators Group[J].Circulation,1995,92∶3255-3263.
  • 10Scheinman MM,Levine JH,Cannom DS,et al.Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias.The Intravenous Amiodarone Multicenter Investigators Group[J].Circulation,1995,92∶3264-3272.

共引文献1397

同被引文献24

  • 1急性心肌梗塞溶栓疗法参考方案（1996年7月修订）[J].中华心血管病杂志,1996,24(5):328-329. 被引量：1321
  • 2王树岩,陈瑾,杨新春,池洪杰,刘秀兰.再灌注心律失常对急性心肌梗死患者心肌细胞凋亡和左室重构的影响[J].中华心血管病杂志,2007,35(1):59-62. 被引量：12
  • 3Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl l Med, 2007, 375(11): 1121-1135.
  • 4Nielsen PH, Terkelsen C], Nielsen TT, et al. System delay and tim- ing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial). The American Journal of Cardiology, 2011, 108(6): 776-781.
  • 5Mehta RH, Starr AZ, Lopes RD, et al. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients un- dergoing primary percutaneous coronary intervention. JAMA, 2009, 301(17): 1179-1189.
  • 6Bolli R, Becket L, Gross G, et al. Myocardial protection at a cross- roads: the need for translation into clinical therapy. Circ Res, 2004, 95(2): 125-134.
  • 7Heper G, Korkmaz ME, Kilic A. Reperfusion arrhythmias: are they only a marker of epicardial reperfusion or continuing myocardial ischemia after acute myocardial infarction? Angiology, 2007, 56(6): 663-670.
  • 8Ide T, Tsutsui H, Kinugawa S, et al. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging ac- tion. Circulation, 1999, 100(7): 690-692.
  • 9Iwamoto T, Watanabe Y, Kita S, et al. Na^+/Ca^2+ exchange inhibitors: a new class of calcium regulators. Cardiovasc Hematol Disord Drug Targets, 2007, 7(3): 188-198.
  • 10Vassallo P, Trohman RG. Prescribing amiodarone: an evidence- based review of clinical indications, lAMA, 2007, 298(11): 1312- 1322.

引证文献4

二级引证文献42

当代医学
2009年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部